The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing

Eur Heart J. 2024 Apr 7;45(14):1183-1187. doi: 10.1093/eurheartj/ehae197.
No abstract available

MeSH terms

  • Arrhythmias, Cardiac / therapy
  • Brugada Syndrome* / complications
  • Brugada Syndrome* / therapy
  • Cardiac Pacing, Artificial
  • Coronary Artery Disease*
  • Equipment Design
  • Heart Failure* / therapy
  • Humans
  • Myocardial Ischemia* / complications
  • Myocardial Ischemia* / therapy
  • Neoplasms*
  • Pacemaker, Artificial*
  • Risk Assessment
  • Treatment Outcome